Vycor Medical Valuation
| VYCO Stock | USD 0.07 0 1.45% |
Vycor Medical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Vycor Medical from inspecting the company fundamentals such as Current Valuation of 4.17 M, shares owned by insiders of 64.50 %, and Return On Asset of -0.24 as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Vycor Medical's price fluctuation is out of control at this time. Calculation of the real value of Vycor Medical is based on 3 months time horizon. Increasing Vycor Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vycor otc stock is determined by what a typical buyer is willing to pay for full or partial control of Vycor Medical. Since Vycor Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vycor OTC Stock. However, Vycor Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.07 | Real 0.0605 | Hype 0.07 |
The intrinsic value of Vycor Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Vycor Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Vycor Medical helps investors to forecast how Vycor otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vycor Medical more accurately as focusing exclusively on Vycor Medical's fundamentals will not take into account other important factors: Vycor Medical Total Value Analysis
Vycor Medical is at this time forecasted to have valuation of 4.17 M with market capitalization of 3.03 M, debt of 150 K, and cash on hands of 43.62 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vycor Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.17 M | 3.03 M | 150 K | 43.62 K |
Vycor Medical Investor Information
About 65.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.02. Vycor Medical had not issued any dividends in recent years. The entity had 1:150 split on the 15th of January 2013. Vycor Medical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Vycor Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vycor Medical has an asset utilization ratio of 148.92 percent. This suggests that the OTC Stock is making $1.49 for each dollar of assets. An increasing asset utilization means that Vycor Medical is more efficient with each dollar of assets it utilizes for everyday operations.Vycor Medical Ownership Allocation
Vycor Medical shows a total of 32.53 Million outstanding shares. Vycor Medical has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.5 % of Vycor Medical outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vycor Medical Profitability Analysis
The company reported the previous year's revenue of 1.39 M. Net Loss for the year was (435.66 K) with profit before overhead, payroll, taxes, and interest of 1.26 M.About Vycor Medical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Vycor Medical. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Vycor Medical based exclusively on its fundamental and basic technical indicators. By analyzing Vycor Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Vycor Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vycor Medical. We calculate exposure to Vycor Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vycor Medical's related companies.Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. Vycor Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 6 people.
8 Steps to conduct Vycor Medical's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Vycor Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vycor Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vycor Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vycor Medical's revenue streams: Identify Vycor Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vycor Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vycor Medical's growth potential: Evaluate Vycor Medical's management, business model, and growth potential.
- Determine Vycor Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vycor Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Vycor Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 30.8 M | |
| Retained Earnings | -31.7 M | |
| Shares Float | 12.1 M |
Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.